a manufacturer of vaccines and cancer immunotherapy products
Industry Biotechnology
A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with ENTA. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then ENTA could also see price increases.
Ticker / NAME | Correlation To ADAP | 1D Price Change % | ||
---|---|---|---|---|
ADAP | 100% | -4.72% | ||
ENTA - ADAP | 35% Loosely correlated | -2.02% | ||
PSTX - ADAP | 34% Loosely correlated | N/A | ||
NUVB - ADAP | 32% Poorly correlated | -7.45% | ||
ABSI - ADAP | 32% Poorly correlated | -9.32% | ||
CYTK - ADAP | 31% Poorly correlated | -4.41% | ||
More |
Ticker / NAME | Correlation To ADAP | 1D Price Change % |
---|---|---|
ADAP | 100% | -4.72% |
cancer theme (87 stocks) | 37% Loosely correlated | +0.89% |
drugs theme (265 stocks) | 37% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 35% Loosely correlated | +5.56% |
europe theme (180 stocks) | 30% Poorly correlated | +0.17% |
immunotherapy theme (13 stocks) | 21% Poorly correlated | -0.95% |
More |